Literature DB >> 15015638

Construction of antisense RNA expression plasmid for u-PAR and its transfection to highly invasive PC-3M cell subclones.

Guoning Liao1, Qingfen Li, Youmei Feng, Yaozu Deng, Zhuoya Li, Feili Gong, Ding Ma.   

Abstract

To evaluate the specific inhibition of antisense u-PAR on the u-PAR expressions in highly invasive cell subclones and to determine its blocking function in the invasion by those cells, a cDNA fragment of u-PAR obtained by RT-PCR was inserted into a plasmid vector named pcDNA3 in antisense orientation. Then the antisense u-PAR recombinant was transfected into highly invasive cell subclones. The u-PAR expression in neo-resistant cells was examined by RT-PCR and immunohistochemical assay. Compared to the control cells, the content of mRNA and protein of u-PAR in transfected cells decreased sharply, and the rate of inhibition was 53% and 73%, respectively, indicating that an antisense u-PAR might have played a specific inhibitory role in its expression in the cells, which may provide a good cell model for making further investigation of the inhibitory effects of the antisense u-PAR on invasion in highly invasive cell subclones of human prostate carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015638     DOI: 10.1007/BF02829420

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

Review 1.  Antisense RNA gene therapy for studying and modulating biological processes.

Authors:  B Weiss; G Davidkova; L W Zhou
Journal:  Cell Mol Life Sci       Date:  1999-03       Impact factor: 9.261

Review 2.  Antisense strategies in dopamine receptor pharmacology.

Authors:  B Weiss; S P Zhang; L W Zhou
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

3.  Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Authors:  Y Wei; D A Waltz; N Rao; R J Drummond; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

4.  Development of a monolayer invasion assay for the discrimination and isolation of metastatic lymphoma cells.

Authors:  H Verschueren; D Dekegel; P De Baetselier
Journal:  Invasion Metastasis       Date:  1987

5.  Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.

Authors:  K Saito; S Takeha; K Shiba; S Matsuno; T Sorsa; H Nagura; H Ohtani
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

Review 6.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

7.  Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization.

Authors:  S Morita; A Sato; H Hayakawa; H Ihara; T Urano; Y Takada; A Takada
Journal:  Int J Cancer       Date:  1998-10-29       Impact factor: 7.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.